How To Make More Xarelto Lawsuit By Doing Less

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to complete so might be grounds for compensation. Our lawyers are functioning tough to have those hurt by the drug the compensation they are entitled to.

Although bleeding is a typical complication linked with anticoagulants, it has been alleged that Xarelto is much more hazardous than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, within the event of an emergency, individuals may possibly be at risk for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging.

If you or even a loved one suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For more details, contact us nowadays to possess your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenditures. Moreover, they may be looking for punitive damages, which are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for a lot more data on the alleged health risks of xarelto lawsuit update.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.